2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells
- 3 January 2013
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 137 (3) , 697-708
Abstract
Since epithelial-mesenchymal transition (EMT) plays a critical role in cancer progression and in maintaining cancer stem cell properties, EMT is emerging as a therapeutic target for inhibiting the metastatic progression of cancer cells. 2′-Hydroxycinnamaldehyde (HCA) and its derivative, 2′-benzoyloxycinnamaldehyde, have recently been suggested as promising therapeutic candidates for cancer treatment. The purpose of this study is to investigate the anti-metastatic effect of HCA on breast cancer and the molecular mechanisms by which HCA regulates the transcriptional program during EMT. HCA induces epithelial reversion at nanomolar concentrations by suppressing Snail via the nuclear translocalization of GSK-3β, which results in the transcriptional upregulation of E-cadherin. HCA also activates the transcription factor KLF17, which suppresses Id-1, indicating that HCA inhibits EMT by multiple transcriptional programs. Further, HCA treatment significantly inhibits lung metastasis in a mouse orthotopic breast cancer model. This study demonstrates the anti-metastatic effect of the non-toxic natural compound HCA through attenuation of EMT in a breast cancer model.Keywords
This publication has 50 references indexed in Scilit:
- MicroRNA Control of Invasion and Metastasis PathwaysFrontiers in Genetics, 2011
- Tumour-initiating cells: challenges and opportunities for anticancer drug discoveryNature Reviews Drug Discovery, 2009
- Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2′-benzoyloxycinnamaldehyde in ratsXenobiotica, 2009
- Micromanagement of metastasisNature, 2007
- Metastasis: recent discoveries and novel treatment strategiesThe Lancet, 2007
- Tumor metastasis: mechanistic insights and clinical challengesNature Medicine, 2006
- Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydesEuropean Journal of Pharmacology, 2006
- 2′-Benzoyloxycinnamaldehyde Induces Apoptosis in Human Carcinoma via Reactive Oxygen SpeciesJournal of Biological Chemistry, 2004
- Inhibition of Human Tumor Growth by 2′-Hydroxy- and 2′-Benzoyl-oxycinnamaldehydesPlanta Medica, 1999
- 2′-Hydroxycinnamaldehyde from Stem Bark ofCinnamomum cassiaPlanta Medica, 1996